How Much Did LSPediA Raise?
Funding & Key Investors

LSPediA has solidified its position as a critical infrastructure provider within the pharmaceutical supply chain, securing a total capital infusion of $357K. This latest financing round, which accounts for $0, underscores the firm's ongoing commitment to scaling its enterprise-grade compliance and serialization platforms. By leveraging this recent investment, the company continues to fortify its market presence, ensuring that stakeholders across the drug distribution network maintain rigorous adherence to evolving regulatory standards.

What is LSPediA?

LSPediA
SoftwareSupply Chain Management (SCM) SoftwareBusiness Intelligence (BI) Software

Founded in 2013, LSPediA operates at the intersection of pharmaceutical logistics and regulatory technology. The company provides a comprehensive suite of turnkey solutions, including its flagship OneScan platform, which serves as the industry benchmark for Drug Supply Chain Security Act (DSCSA) compliance. Beyond mere regulatory adherence, the firm offers the Investigator software, a pioneering collaborative tool designed to automate the resolution of complex transaction data and logistics exceptions. By integrating business intelligence with real-time traceability, LSPediA enables pharmaceutical manufacturers, wholesalers, and dispensers to mitigate operational risks while enhancing supply chain transparency. Its market position is defined by a focus on high-stakes compliance, where the cost of failure is significant, making its automated, cloud-based architecture an essential component of modern pharmaceutical operations.

How much funding has LSPediA raised?

LSPediA has raised a total of $357K across 2 funding rounds:

2020

Debt

$150K

2021

Debt

$207K

Debt (2020): $150K with participation from PPP

Debt (2021): $207K led by PPP

Key Investors in LSPediA

PPP

Public-Private Partnership

What's next for LSPediA?

With this late-stage capital injection, LSPediA is well-positioned to accelerate its product roadmap and expand its footprint in the global life sciences sector. The strategic focus will likely shift toward deepening the integration of artificial intelligence within its Investigator platform to further reduce manual intervention in exception management. As the regulatory landscape for pharmaceutical traceability becomes increasingly complex, the company is expected to leverage its financial backing to enhance its interoperability features, ensuring seamless data exchange across disparate supply chain nodes. Furthermore, the firm may explore inorganic growth opportunities or strategic partnerships to broaden its service offerings, ultimately aiming to become the definitive operating system for pharmaceutical supply chain integrity and operational excellence.

See full LSPediA company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Engineering SoftwareSoftware
Multimedia, Games & Graphics SoftwareSoftware
SoftwareSupply Chain Management (SCM) SoftwareMobile App Development
Customer Engagement PlatformsSoftware

Frequently Asked Questions Regarding LSPediA Financial Insights

What are the most recent funding rounds that LSPediA has completed, and what were the funding rounds?
LSPediA has recently completed 2 funding rounds: Debt on Jan 26, 2021, Debt on Apr 7, 2020.
What is the total amount of funding LSPediA has raised to date?
LSPediA has raised a total of $357K in funding to date.
How many funding rounds has LSPediA completed?
LSPediA has completed 2 funding rounds.
How much funding did LSPediA raise in its most recent funding round?
LSPediA raised $207K in its most recent funding round.
Who are the lead investors in LSPediA's latest funding round?
The lead investor in LSPediA's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in LSPediA's history?
The largest funding round in LSPediA's history was $207K.
See more information about LSPediA